Our Clinical Studies
Our Program
Through a proprietary technology, our incisionless treatment leverages a controlled cooling process to reduce tissue and open airways.
Our commitment to improving people’s lives by solving obstructive sleep apnea (OSA) starts with our clinical program.
Cryosa is currently enrolling participants in a U.S. pilot study (ARCTIC-3) to evaluate the safety and effectiveness of our therapy to treat OSA patients with moderate to severe disease. Current geographies include New York, Pennsylvania, Illinois, Colorado, Houston, Tennessee, and Florida, with others soon to follow. Click below to see if there is a site near you.
Our Studies
Cryosa conducted a peer-reviewed preclinical study evaluating selective adipose cryolysis for reducing tongue fat, a key contributor to obstructive sleep apnea.
The research demonstrated meaningful fat reduction and supported the safety of the approach in a validated model.
These findings help inform future clinical development and treatment.